FDA panel backs approval of women's libido drug

June 4, 2015 8:21 PM

31 0

WASHINGTON A drug to treat low female sexual desire should be approved with strict procedures in place to ensure patients are fully aware of its risks, including fainting and low blood pressure, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.

The FDA, which has twice rejected the drug, flibanserin, is not obliged to follow the advice of its advisory panels but typically does so.

Also read: FDA clears 1st generic film strip of addiction drug Suboxone

Read more

To category page